Skip to main content
. 2022 Oct 12;149(8):4701–4717. doi: 10.1007/s00432-022-04391-6

Fig. 1.

Fig. 1

Nanoparticle tracking analysis for serum- and urine-derived EV. A Number of nanoparticles/mL and B average nanoparticle size (nm) after EV isolation. Serum samples: control n = 3, CRPC n = 15; urine samples: control n = 3, PCa n = 12. *p < 0.05